Traws Pharma grants 14,150 stock options to director
Traws Pharma director Mary Teresa Shoemaker received a grant of stock options for 14,150 shares of common stock on July 9, 2026 at an exercise price of $0.68 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Traws Pharma director Mary Teresa Shoemaker received a grant of stock options for 14,150 shares of common stock on July 9, 2026 at an exercise price of $0.68 per share. Granted under the 2021 Incentive Compensation Plan, the options vest 100% on the first anniversary of the grant date and expire on July 9, 2036, and are held directly.
Insider Trade Summary
Grant/Award: 14,150 shares
Grant/Award
1 txn
Insider
Shoemaker Mary Teresa
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 14,150 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 14,150 contracts (Direct)
Holdings Before and After:
Stock Option (right to buy), 0 to 14,150 contracts (Direct)
Footnotes (1)
- F1. Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.
Key Figures
Options granted: 14,150 options
Exercise price: $0.68 per share
Underlying shares: 14,150 shares
+4 more
7 metrics
Options granted
14,150 options
Stock options for common stock granted to director Mary Teresa Shoemaker on July 9, 2026
Exercise price
$0.68 per share
Conversion or exercise price of the granted stock options
Underlying shares
14,150 shares
Common shares underlying the granted stock options
Expiration date
2036-07-09
Expiration date of the stock options awarded to Shoemaker
Exercise date
2027-07-09
Date from which the stock options are first exercisable under their terms
Post-grant derivative holdings
14,150 options
Total derivative securities held directly after the reported grant
Vesting at first anniversary
100%
Portion of the option award that vests on the first anniversary of the grant date
Key Terms
Stock Option (right to buy), 2021 Incentive Compensation Plan, vesting, grant date
4 terms
Stock Option (right to buy) financial
"Security titled Stock Option (right to buy) awarded to the reporting person"
2021 Incentive Compensation Plan financial
"Awarded under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated"
vesting financial
"The stock options under this award will vest 100% on the first anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant date financial
"Will vest 100% on the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Mary Teresa Shoemaker receive from Traws Pharma (TRAW)?
Mary Teresa Shoemaker received 14,150 stock options for Traws Pharma common stock at an exercise price of $0.68 per share. The options are held directly, relate to 14,150 underlying shares, and were granted as director compensation on July 9, 2026.
When do Mary Teresa Shoemaker’s new TRAW stock options vest?
The stock options will vest 100% on the first anniversary of the July 9, 2026 grant date. This means the entire 14,150-option award becomes fully vested after one year, subject to the terms of Traws Pharma’s 2021 Incentive Compensation Plan.
What is the exercise price and expiration date of Shoemaker’s TRAW options?
Shoemaker’s options have an exercise price of $0.68 per share and an expiration date of July 9, 2036. They cover 14,150 underlying common shares, providing a long-dated equity incentive if the options are exercised before expiration.
Under which plan were Mary Teresa Shoemaker’s TRAW stock options granted?
The options were granted under Traws Pharma’s 2021 Incentive Compensation Plan, as amended and/or restated. The grant was approved by the company’s compensation committee, which is comprised of independent directors, and represents equity-based compensation for Shoemaker.
How many TRAW derivative securities does Shoemaker hold after this stock option grant?
Following the award, Shoemaker holds 14,150 stock options directly, according to the reported holdings after the transaction. These derivative securities correspond to 14,150 shares of Traws Pharma common stock if exercised under the specified option terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
